Koichiro Sakai
Stanford University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Koichiro Sakai.
Journal of Neuroimmunology | 1988
Koichiro Sakai; Scott S. Zamvil; Dennis J. Mitchell; Lim Mae; B Rothbard Jonathan; Steinman Lawrence
The C-terminal 89-169 amino acid fragment of myelin basic protein (MBP) causes experimental allergic encephalomyelitis (EAE) in SJL/J mice. In order to identify the encephalitogenic T cell epitope, we have examined the fine specificity of encephalitogenic SJL/J T cell clones with synthetic peptides derived from the C-terminal 89-169 amino acids of MBP. These peptides were examined for their immunogenic and encephalitogenic activity in the SJL/J mouse. The SJL/J-derived, encephalitogenic T cell clone, 4b.14a, was shown to be responsive to rat myelin basic protein synthetic peptides pR89-101 (VHFFKNIVTPRTP) as well as to intact MBP. Its response was effectively blocked by mAb 10-2.16 (anti-I-As) as was the response to intact MBP. Furthermore, pR89-101 was revealed to be highly immunogenic for the (PLSJ)F1 mouse in terms of lymphocyte proliferation, but not for the PL/J mouse, in spite of the fact that there exists a strong bias to H-2u restricted responses in the (PLSJ)F1 mouse at the T cell level. By using pR89-101, T cells of (PLSJ)F1 origin were revealed to recognize the peptide in association with the I-As molecule on (PLSJ)F1 antigen presenting cells (APC). When examined for encephalitogenicity for the SJL/J mouse, pR89-101 was found to be as encephalitogenic as intact rat MBP. These results demonstrated that MBP peptide pR89-101 is a major encephalitogenic determinant for the SJL/J mouse.
Human Immunology | 1990
Ann B. Begovich; Rhea Helmuth; Jorge R. Oksenberg; Koichiro Sakai; Takeshi Tabira; Takehiko Sasazuki; Lawrence Steinman; Henry A. Erlich
Nonradioactive sequence-specific oligonucleotide (SSO) probes specific for the HLA-DP beta locus have been used in a simple dot-blot assay to DP beta-type samples amplified by the polymerase chain reaction (pcr) from Caucasoid (n = 24) and Japanese (n = 23) patients with multiple sclerosis (ms) as well as ethnically matched controls. In contrast to previous reports, no DP beta allele was found to be increased in either patient population. However, the results do show a dramatic difference in the allele frequencies between the two control populations, further emphasizing the need for ethnically matched controls in studies of HLA and disease.
Journal of Neuroimmunology | 1985
Koichiro Sakai; Tadashi Namikawa; Tatsuhide Kunishita; T. Yoshimura; Takeshi Tabira
To clarify the functional role of the I region-associated (Ia) antigen in autoimmune central nervous system disorders, we generated long-term cultured lines of encephalitogenic T cells responsive to myelin basic protein from SJL strain mice (H-2s) and investigated genetic restriction in proliferative and encephalitogenic activities of the lines. These cell lines bear a Lyt 1+,2- phenotype, and show antigen-specific and I-As restricted proliferative responses in vitro. These lines induced full-blown experimental allergic encephalomyelitis (EAE) in immuno-compromised recipients carrying the I-As genotype. These data demonstrate that encephalitogenic T lymphocytes recognize the antigen in combination with the Ia antigen to induce EAE.
International Archives of Allergy and Immunology | 1986
Tadashi Namikawa; Takashi Yamamura; Koichiro Sakai; Tatsuhide Kunishita; Takeshi Tabira
We studied the mechanism of activation of effector cells in experimental allergic encephalomyelitis (EAE) by using T-cell lines (EAE/TL) reactive against guinea pig myelin basic protein generated from in vivo primed lymph node cells (LNC) of Lewis rats. EAE-effector cells are activated in the presence of a specific antigen and antigen-presenting cells (APC) with a compatible Ia antigen. The antigen presentation occurs during the first 18 h. EAE-effector cells cannot be activated by allogeneic stimulator cells, but a nonspecific T-cell mitogen, concanavalin A, can activate the effector cells in the presence of syngeneic as well as allogeneic APC.
Journal of Experimental Medicine | 1988
Scott S. Zamvil; Dennis J. Mitchell; Nadine E. Lee; Anne C. Moore; Matthew K. Waldor; Koichiro Sakai; Jonathan B. Rothbard; Hugh O. McDevitt; Lawrence Steinman; Hans Acha-Orbea
Proceedings of the National Academy of Sciences of the United States of America | 1988
Koichiro Sakai; Animesh A. Sinha; Dennis J. Mitchell; Scott S. Zamvil; Jonathan B. Rothbard; Hugh O. McDevitt; Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America | 1989
Koichiro Sakai; Scott S. Zamvil; Dennis J. Mitchell; Suzanne J. Hodgkinson; Jonathan B. Rothbard; Lawrence Steinman
Journal of Immunology | 1987
Jun-ichi Satoh; Koichiro Sakai; Masumi Endoh; Fumihiko Koike; Tatsuhide Kunishita; Tadashi Namikawa; Takashi Yamamura; Takeshi Tabira
Biochemical and Biophysical Research Communications | 1994
Koichiro Sakai; M. Gofuku; Y. Kitagawa; T. Ogasawara; G. Hirose; M. Yamazaki; Chang-Sung Koh; N. Yanagisawa; Lawrence Steinman
Journal of Experimental Medicine | 1988
Scott S. Zamvil; Dennis J. Mitchell; Marianne Broome Powell; Koichiro Sakai; Jonathan B. Rothbard; Lawrence Steinman